@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix go: . @prefix pfm: . @prefix hasAgent: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:97275; a Protein: . sub:_2 hasAgent: sub:_3; a go:0042789 . sub:_3 geneProductOf: pfm:Mef2%20Family; a Protein: . sub:_4 occursIn: species:10090; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(MGI:Myod1) -> tscript(p(PFM:\"Mef2 Family\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "1.4" . sub:_5 prov:value "To test whether pRb is required for MyoD to activate the MEF2C TAD, we transfected Rb-/- fibroblasts with the Gal4-MEF2C fusion protein either alone or with MyoD and E12, in either the absence or the presence of exogenous pRb. When expressed alone, MyoD+E12 did not significantly stimulate Gal4-MEF2C function in these cells (Figure 3c, column 4). Similarly, the expression of pRb alone did not affect the activity of Gal4-MEF2C (Figure 3c, column 5); but, the combined expression of MyoD+E12 and pRb led to a 45-fold increase in the activity of Gal4-MEF2C (Figure 3c, column 6). These findings indicate that MyoDmediated activation of the MEF2C TAD requires pRb."; prov:wasQuotedFrom pubmed:10322110 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10322110; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:47.103+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }